Cambridge Cancer Genomics

Cambridge Cancer Genomics (CCG.ai) was founded with the mission of ensuring every cancer patient receives the most appropriate treatment at the optimal time to combat their disease. The company focused on developing software solutions to facilitate data-driven precision oncology, with a systematic approach to identifying data-driven biomarkers that could predict treatment response. CCG.ai believed that the growing volume of clinical and genomic data held immense potential to revolutionize cancer treatment, empowering oncologists to make more informed decisions regarding drug selection for specific patient circumstances. The company sought dedicated individuals to join their team in Cambridge, UK, offering a dynamic and challenging environment with opportunities for significant impact. They offered competitive compensation, performance-based bonuses, stock options, and career advancement within a rapidly growing startup.